(Q44060182)

29 November 2017

title

Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis (English)

1 reference

29 November 2017

1 reference

2

Elan D Louis

1 reference

29 November 2017

Anjan Chatterjee

1

1 reference

29 November 2017

Steven Frucht

series ordinal

3

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

17

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

614-615

1 reference

Familial (idiopathic) paroxysmal dyskinesias: an update

29 November 2017

cites work

1 reference

Paroxysmal kinesignenic choreoathetosis. Report of a case relieved by carbamazepine

21 January 2018

1 reference

Levetiracetam. A review of its adjunctive use in the management of partial onset seizures

21 January 2018

1 reference

The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes

21 January 2018

1 reference

Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs

21 January 2018

1 reference

A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus

21 January 2018

1 reference

An assessment of levetiracetam as an anti-epileptic drug

21 January 2018

1 reference

Paroxysmal kinesigenic choreoathetosis: An entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases, including 1 autopsied

21 January 2018

1 reference

Exquisite sensitivity of paroxysmal kinesigenic choreoathetosis to carbamazepine

21 January 2018

1 reference

Therapeutic aspects of kinesiogenic paroxysmal choreoathetosis and familial paroxysmal choreoathetosis of the Mount and Reback type

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.10118

1 reference

29 November 2017

1 reference